Literature DB >> 15531024

Non-invasive evaluation of endothelial function in hypertensive elderly patients.

Bulent Saka1, Huseyin Oflaz, Nilgun Erten, Gulistan Bahat, Memduh Dursun, Burak Pamukcu, Fehmi Mercanoglu, Mehmet Meric, M Akif Karan.   

Abstract

Impaired endothelium-dependent vasomotion is a diffuse disease process resulting in abnormal regulation of blood vessel tone and loss of several atheroprotective effects of the normal endothelium. The aim of the present study was to investigate the effects of aging and hypertension on endothelial function. Sixty-six geriatric subjects with ages over 60 (48 hypertensive and 18 healthy) and 40 middle-aged subjects (16 hypertensive and 24 healthy) were included in the study. Systemic vascular endothelial function was evaluated through measuring brachial arterial vasodilation, a physiologic answer to reactive hyperemia occured with increased blood flow in the vessel after transient ischemia (flow-mediated dilation, FMD%), and with carotid artery intima-media thickness (IMT) measurement, using high-resolution ultrasonography. Endothelial independent vasodilation was also measured after administration of sublingual isosorbide dinitrate (isosorbide dinitrate mediated dilation, IDNMD%). FMD% was significantly decreased in elderly and/or hypertensive (HT) patients (geriatric HT: 9.5 +/- 4.7%, geriatric non-HT: 12.7 +/- 5.5%, middle-aged HT: 12.9 +/- 4.3% and middle-aged non-HT: 18.9 +/- 8.1%) (geriatric HT versus geriatric non-HT (P = 0.02), geriatric HT versus middle-aged HT (P = 0.01), geriatric non-HT versus middle-aged non-HT (P = 0.008)). Both FMD% and IDNMD% were inversely correlated with age, baseline vessel diameter and carotid artery intima-media thickness. FMD% was also inversely correlated with diastolic blood pressure. No correlation was found between FMD% and systolic blood pressure, serum cholesterol and triglyceride levels. Endothelium dependent (EDD) and independent dilatation of large arteries decreased with aging even in the healthy elderly, and FMD further declined in HT elderly patients, indicating that age and hypertension independently impair endothelial function. Positive correlations with age and hypertension, and significant inverse correlation with FMD, makes carotid artery IMT a possible indicator of endothelial function.

Entities:  

Mesh:

Year:  2005        PMID: 15531024     DOI: 10.1016/j.archger.2004.05.008

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  5 in total

1.  Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients.

Authors:  Emin Alioglu; Ugur O Turk; Firat Bicak; Istemihan Tengiz; Dincer Atila; Vatan Barisik; Ertugrul Ercan; Mustafa Akin
Journal:  Clin Res Cardiol       Date:  2008-03-17       Impact factor: 5.460

2.  Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats.

Authors:  Frederic Pinaud; Arnaud Bocquet; Odile Dumont; Kevin Retailleau; Christophe Baufreton; Ramaroson Andriantsitohaina; Laurent Loufrani; Daniel Henrion
Journal:  Hypertension       Date:  2007-05-07       Impact factor: 10.190

Review 3.  Cerebral endothelial function determined by cerebrovascular reactivity to L-arginine.

Authors:  Janja Pretnar-Oblak
Journal:  Biomed Res Int       Date:  2014-04-17       Impact factor: 3.411

4.  Assessment of Endothelial Dysfunction by Brachial Artery Flow-Mediated Dilatation in Postmenopausal Women at Low Risk for Cardiovascular Disease.

Authors:  Piyushi Sharad; Neha Agarwal; Seema Chopra; Vanita Jain; Pooja Sikka; Ajay Bahl; Nayana Gaba
Journal:  J Midlife Health       Date:  2021-10-16

5.  Coronary microvascular function in patients with isolated systolic and combined systolic/diastolic hypertension.

Authors:  Huseyin Bozbas; Bahar Pirat; Aylin Yildirir; Serpil Eroglu; Vahide Simsek; Elif Sade; Ilyas Atar; Alp Aydinalp; Bulent Ozin; Haldun Muderrisoglu
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-27       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.